David A. Krantz
NTD Laboratories Inc.
403 Oakwood Road
Huntington Station
NY 11746
USA
Name/email consistency: high
- Genetic sonography after first-trimester Down syndrome screening. Krantz, D.A., Hallahan, T.W., Macri, V.J., Macri, J.N. Ultrasound. Obstet. Gynecol (2007)
- First-trimester maternal dried blood Down syndrome screening marker levels in early pregnancy loss. Krantz, D., Hallahan, T., Ishack, S., Macri, V.J., Macri, J.N. Prenat. Diagn. (2006)
- Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Krantz, D.A., Hallahan, T.W., Macri, V.J., Macri, J.N. Prenat. Diagn. (2005)
- Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Krantz, D., Goetzl, L., Simpson, J.L., Thom, E., Zachary, J., Hallahan, T.W., Silver, R., Pergament, E., Platt, L.D., Filkins, K., Johnson, A., Mahoney, M., Hogge, W.A., Wilson, R.D., Mohide, P., Hershey, D., Wapner, R. Am. J. Obstet. Gynecol. (2004)
